Closed System Transfer Devices Market Size, Share By Type (Needleless Systems and Membrane-to-Membrane Systems), By Closing Mechanism (Color-To-Color Alignment Systems, Push-To-Turn Systems, Click-To-Lock Systems, and Luer-Lock Systems), By Component (Syringe Safety Devices, Vial Access Devices, Accessories, and Bag/Line Access Devices), By End User (Clinics & Oncology Centers, Hospitals, and Others) - Global Industry Analysis, Growth, Trends Analysis, Segment Forecasts, Regional Outlook 2023 - 2032


The global closed system transfer device market size reached USD 1,268.9 million in 2023 and is expected to hit around USD 4,863.3 million by 2032, poised to grow at a CAGR of 16.1% during the forecast period from 2023 to 2032.

Closed System Transfer Device Market Size 2023 to 2032

To Access our Exclusive Data Intelligence Tool with 15000+ Database, Visit: Precedence Statistics

Key Takeaways

  • North America led the global market with the highest market share in 2022.
  • By Type, the membrane-to-membrane systems segment had the biggest market share in 2022.
  • By Closing Mechanism, the push-to-turn systems segment is estimated to hold the highest market share in 2022.
  • By End User, the hospitals segment has held the largest revenue share in 2022.

Closed System Transfer Device Market in the U.S. 2023 To 2032

The U.S. closed system transfer device market size was valued at USD 337.25 million in 2023 and is expected to reach USD 1,282.53 million by 2032, growing at a CAGR of 16% from 2023 to 2032.

U.S. Closed System Transfer Device Market Size 2023 to 2032

North America is Estimated to be the Largest Market for Closed System Transfer Device

The research report covers key trends and prospects of closed system transfer device products across different geographical regions including North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Geographically, the closed system transfer device market is conquered by North America owing to a high incidence of cancer and the presence of a sophisticated healthcare framework. On the other hand, Asia-Pacific is anticipated to witness a rapid growth rate, on account of increasing healthcare expenditure and growing investment by major manufacturers to launch new products.

Key market Insights:

The requirement for (CSTDs) closed system transfer devices is increasing rapidly, due to the increasing occurrence of cancer, the rising implementation of CSTDs for transporting hazardous medications, such as cytotoxic or antineoplastic drugs, the increasing need for monitoring compliance for safe management of injurious drugs, and escalating quantity of drug sanctions for cancer. These are some key factors driving the global closed system transfer device market. Moreover, closed system transfer devices support circumventing environmental contamination with damaging drugs resulting in augmented device adoption, which in turn, drives market development. The use of closed system transfer devices for other healing applications and the quick use of CSTDs in developing markets are projected to generate new growth opportunities for the worldwide closed system transfer device market.

Closed System Transfer Devices Market Scope 

Report Highlights Details
Market Size in 2023 USD 1,268.97 Million
Market Size by 2032 USD 4,863.3 Million
Growth Rate from 2023 to 2032 CAGR of 16.1%
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered Type, Component, End User, Closing Mechanism, Region
Companies Mentioned Baxter International Inc., Becton, Dickinson, and Company, CodanMedizinischeGeräte GmbH & Co Kg, ICU Medical, Inc., Yukon Medical, B. Braun Melsungen, Equashield, Teva Pharmaceutical Industries Ltd., Victus, Inc., and Corvida Medical

 

Crucial factors accountable for market growth are:

  • Increasing prevalence of cancer
  • Growing need for regulatory compliance for the safe handling of harmful drugs
  • Rising adoption of closed-system transfer devices for transferring hazardous drugs
  • Increasing use of CSTDs in emerging markets

Type Insights

Membrane-to-Membrane Systems Segment Seized Foremost Market Stake in 2022

Membrane-to-Membrane Systems segment recorded the prime market share in the global closed-system transfer device Market in 2022. The membrane-to-membrane transference devices use the dual membrane system among the syringe and vial further supports to isolate the medical preparation. The factors such as reduced contamination risk, and ease of usage of the double-membrane systems confirm the safety expected to increase the usage of the membrane-to-membrane transmission devices over the estimated period.

The needleless systems are projected to grow at the highest CAGR during the forecast period mainly due to benefits such as needle-free transmission of drugs. Moreover, new product launches are expected to contribute to the high growth of needleless systems.

Closing Mechanism Insights

Push-To-Turn Systems Projected to Rulethe Closing Mechanism Segment of Closed System Transfer Device Market Revenue

Closed system transfer devices are rapidly being employed for the safe transfer of harmful medical preparations. High research and development activity in closed-system transfer devices for the transfer of oncology medications is the major reason for the high revenue share of closed-system transfer devices.

The luer-lock systems segment will expand at the highest CAGR during the forecast time frame.

End User Insights

Hospitals Projected to Dominate the End-User Segment of Closed System Transfer Device Market Revenue

Hospitals have the funds to procure expensive closed-system transfer devices that help in the safe transfer of hazardous medical preparations when compared to small clinics and oncology centers.

Closed System Transfer Devices Market Players

The companies focusing on research and development are expected to lead the global closed system transfer device market. Leading competitors contending in the global closed system transfer device market are as follows:

  • Baxter International Inc.
  • Becton, Dickinson, and Company
  • CodanMedizinischeGeräte GmbH & Co Kg
  • ICU Medical, Inc.
  • Yukon Medical
  • Braun Melsungen
  • Equashield
  • Teva Pharmaceutical Industries Ltd.
  • Victus, Inc.
  • Corvida Medical

In order to better recognize the current status of closed system transfer devices, and policies adopted by the foremost countries, Precedence Research predicted the future evolution of the closed system transfer device market. This research study bids qualitative and quantitative insights into the closed system transfer device market and assessment of the market size and growth trends for potential market segments.

Major Market Segments Covered:

By Type

  • Needleless Systems
  • Membrane-to-Membrane Systems

By Closing Mechanism

  • Color-To-Color Alignment Systems
  • Push-To-Turn Systems
  • Click-To-Lock Systems
  • Luer-Lock Systems

By Component

  • Syringe Safety Devices
  • Vial Access Devices
  • Accessories
  • Bag/Line Access Devices

By End User

  • Clinics & Oncology Centers
  • Hospitals
  • Others

By Geography

    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • France
      • United Kingdom
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Southeast Asia
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Rest of Latin America
    • Middle East & Africa (MEA)
      • GCC
      • North Africa
      • South Africa
      • Rest of Middle East & Africa

Frequently Asked Questions

What is the current size of the global closed system transfer device market?
According to Precedence Research, the global closed system transfer device market size stood at USD 1,268.9 million in 2023 and is predicted to reach USD 4,863.3 million by the end of 2032.
What is the CAGR of closed system transfer device market?
The global closed system transfer device market is growing at a CAGR of 16.1% during the forecast period 2023 to 2032.
What are the growth factors of the closed system transfer device market?
Factors such as growing prevalence of cancer and rising need for monitoring compliance for harmless handling of damaging drugs are driving the growth of closed system transfer device market.
How much is the North America closed system transfer device market share?
In 2022, North America dominated the global market with a market share of more than 42%.
How much is the CAGR of Asia Pacific closed system transfer device market?
Asia Pacific is anticipated to grow at the maximum CAGR of around 18% in the forecast period due to high incidence of cancer.
Which major companies are operating in the closed system transfer device market?
The major companies operating in the worldwide closed system transfer device are Baxter International Inc., Becton, Dickinson, and Company, CodanMedizinischeGeräte GmbH & Co Kg, ICU Medical, Inc., Yukon Medical, B. Braun Melsungen, Equashield, Teva Pharmaceutical Industries Ltd., Victus, Inc., and Corvida Medical among others.
Which segment accounted largest share in the closed system transfer device market?
Push-To-Turn systems projected to rule the closing mechanism segment of closed system transfer device market revenue.
Which end use segment is projected to dominate the closed system transfer device market?
Hospitals Projected to Dominate the End-User Segment of Closed System Transfer Device Market Revenue.

PROCEED TO BUY :

   USD 4900
   USD 3800
   USD 2100
   USD 2100
   USD 7500

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

Get a Sample